Business Wire: Cardax Astaxanthin Compound Chosen for Important NIH Anti-Aging Research Program

June 1, 2017

Cardax, Inc. (“Cardax”) (OTCQB:CDXI) and the University of Hawaii (“UH”) announced today that the National Institute on Aging (“NIA”), one of the federal government’s National Institutes of Health (“NIH”), has selected Cardax’s proprietary astaxanthin compound CDX-085 for its anti-aging Interventions Testing Program (“ITP”). Only 4-5 compounds per year are typically chosen by the NIA for […]